Sernova Corp T.SVA

Alternate Symbol(s): SEOVF

Healthcare Biotechnology

Sernova Corp. is a Canada-based clinical-stage biotechnology company, which is developing therapeutic cell technologies for chronic diseases, including insulin-dependent diabetes, thyroid disease, and blood disorders that include hemophilia A. The Company is focused on developing a functional cure for insulin-dependent diabetes with its therapeutic cell technology, the Cell Pouch System, a novel implantable and scalable medical device with immune protected therapeutic cells. The Cell Pouch is a scalable, implantable medical device. The Cell Pouch is designed to create a vascularized organ-like environment for the transplantation and engraftment of therapeutic cells. Its regenerative medicine therapeutic approach is to provide cell therapies where the cells, transplanted within an organ-like vascularized implantable device, the Cell Pouch, generates proteins, hormones or factors released into the bloodstream for treatment of diseases requiring replacement of these molecules in the body.

TSX:SVA - Post by User

Sernova Corp > 1,2x

<< Previous

Bullboard Posts

Next >>

Comment by Redbaron2211on Jun 14, 2022 2:06pm

148 Views

Post# 34755707

RE:RE:1,2x

The way I see it at least from a shareholders perspective is that it's a tragedy we couldn't get to this stage in 2021. It's a major accomplishment but we are now in a tightening environment and there isn't an ounce of speculative froth to be had. On a positive note the science has major potential and we are cashed up for 3 years so even though we are more than likely heading into a major recession in 2023 at least we don't have to worry about raising cash and we should have the valuation underpinned by the $1.5-2.5 investment by Evotec. Unfortunately no easy out and it's back to a long game with some derisking and hopefully some quicker progress moving forward that should help increase shareholder value. Even in a bear market there are major rallies and the quality quickly rises to the top.

As for Sernova's current price action it is following the sector and in line with companies like Evotec. No more carrot to dangle and keep things range bound like the previous 4 months volatility will come out as we grind this out with the rest of the market and those looking to accumulate will be able to do so.

Evotec chart with SVA (teal) and VanEck Biotech ETF (BBH) (Orange)
User image